| Christine Petricek Hans, MD | |
|
8303 Dodge St, Omaha, NE 68114-4108 | |
| (402) 354-4540 | |
| (402) 354-4535 |
| Full Name | Christine Petricek Hans |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 28 Years |
| Location | 8303 Dodge St, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033168398 | NPI | - | NPPES |
| 47068731746 | Medicaid | NE | |
| 1033168398 | Medicaid | IA | |
| 47037660422 | Medicaid | NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Cass County Memorial Hospital | Atlantic, IA | Hospital |
| Clarinda Regional Health Center | Clarinda, IA | Hospital |
| Montgomery County Memorial Hospital | Red oak, IA | Hospital |
| Methodist Jennie Edmundson | Council bluffs, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nebraska Methodist Hospital | 6901707447 | 118 |
| Methodist Fremont Health | 7911258520 | 67 |
| Jennie Edmundson Memorial Hospital | 9537064837 | 32 |
News Archive
...based on matching paired images using internal fingerprint structures that would be difficult to fake, offering the possibility of a unique automated fingerprint identification system, according to a new study by researchers from the University of Michigan in Ann Arbor.
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
In a paper published today in the professional health care journal, Health Affairs, Blue Cross Blue Shield of Michigan and the University of Michigan Health System report that their model for collaborative health care quality improvement has measurably improved safety and quality in several clinical areas, and has saved millions in health care costs.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
› Verified 6 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
...based on matching paired images using internal fingerprint structures that would be difficult to fake, offering the possibility of a unique automated fingerprint identification system, according to a new study by researchers from the University of Michigan in Ann Arbor.
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
In a paper published today in the professional health care journal, Health Affairs, Blue Cross Blue Shield of Michigan and the University of Michigan Health System report that their model for collaborative health care quality improvement has measurably improved safety and quality in several clinical areas, and has saved millions in health care costs.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
› Verified 6 days ago
| Entity Name | Methodist Fremont Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235618216 PECOS PAC ID: 7911258520 Enrollment ID: O20181017000110 |
News Archive
...based on matching paired images using internal fingerprint structures that would be difficult to fake, offering the possibility of a unique automated fingerprint identification system, according to a new study by researchers from the University of Michigan in Ann Arbor.
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
In a paper published today in the professional health care journal, Health Affairs, Blue Cross Blue Shield of Michigan and the University of Michigan Health System report that their model for collaborative health care quality improvement has measurably improved safety and quality in several clinical areas, and has saved millions in health care costs.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Petricek Hans, MD Po Box 2797, Omaha, NE 68103-2797 Ph: (402) 354-4230 | Christine Petricek Hans, MD 8303 Dodge St, Omaha, NE 68114-4108 Ph: (402) 354-4540 |
News Archive
...based on matching paired images using internal fingerprint structures that would be difficult to fake, offering the possibility of a unique automated fingerprint identification system, according to a new study by researchers from the University of Michigan in Ann Arbor.
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression, UT Southwestern Medical Center researchers report today in Cancer Cell.
In a paper published today in the professional health care journal, Health Affairs, Blue Cross Blue Shield of Michigan and the University of Michigan Health System report that their model for collaborative health care quality improvement has measurably improved safety and quality in several clinical areas, and has saved millions in health care costs.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
› Verified 6 days ago
Audrey J Lazenby, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4186 Fax: 402-559-6018 | |
Shane K. Kohl, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Stanley J Radio, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4186 Fax: 402-559-6018 | |
Dr. Diana L Nevins, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Dr. Marc R Hapke, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 909 N 96th St, Suite 201, Omaha, NE 68114 Phone: 402-330-4555 Fax: 402-934-0945 | |
Bryan Scott Teruya, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 4101 Woolworth Ave, Department Of Pathology, Omaha, NE 68105 Phone: 402-995-3218 |